Ochi K, Katz E
J Antibiot (Tokyo). 1978 Nov;31(11):1143-8. doi: 10.7164/antibiotics.31.1143.
The treatment of Streptomyces parvulus and Streptomyces antibioticus with acriflavine or novobiocin resulted in the loss of ability to produce actinomycin. The concomitant loss of ability to form aerial mycelium and the incidence of auxotrophic progeny (S. parvulus) were both low relative to the loss of the antibiotic-producing property. Protoplast fusion induced by polyethylene glycol 4000, using suitable auxotrophic strains of S. parvulus, resulted in high recombination frequencies to prototrophy (9.6 approximately 15%). When fusion was carried out between auxotrophic act+ and act- strains, respectively, there was a high frequency (84 approximately 95%) of the actinomycin synthesizing character among the prototrophic recombinants examined. No actinomycin-producing recombinant was detected in similar experiments between auxotrophic non-producing strains.
用吖啶黄素或新生霉素处理微小链霉菌和抗生链霉菌,导致其产生放线菌素的能力丧失。与抗生素产生特性的丧失相比,形成气生菌丝体能力的伴随丧失以及营养缺陷型后代(微小链霉菌)的发生率均较低。使用合适的微小链霉菌营养缺陷型菌株,通过聚乙二醇4000诱导原生质体融合,产生原养型的重组频率很高(约9.6%至15%)。当分别在营养缺陷型的产放线菌素菌株和不产放线菌素菌株之间进行融合时,在所检测的原养型重组体中,放线菌素合成特性的频率很高(约84%至95%)。在营养缺陷型不产菌株之间的类似实验中未检测到产放线菌素的重组体。